Home › Mga Employer › Merck Sharp & Dohme LLC › Senior Scientist, Preclinical Development
Senior Scientist, Preclinical Development sa Merck Sharp & Dohme LLC: Sahod ng H-1B
23 aplikasyon para sa kondisyon ng trabaho para sa posisyong Senior Scientist, Preclinical Development sa Merck Sharp & Dohme LLC. Median na alok na base salary $114,700; gitnang kalahati $114,700–$118,394.
Mga Aplikasyon (LCAs)23
Median na sahod na iminungkahi$114,700
Gitnang bahagi ng mga sahod$114,700–$118,394
Ika-10 hanggang ika-90 percentil$111,463–$123,594
Ayon sa fiscal year
| Piskal na taon | LCAs | Median na sahod |
|---|---|---|
| FY2023 | 2 | $111,717 |
| FY2024 | 3 | $111,400 |
| FY2025 | 10 | $114,700 |
| FY2026 | 8 | $123,594 |
Mga Aplikasyon
| Batayang sahod | Lokasyon | Isumite | Petsa ng Simula | Status |
|---|---|---|---|---|
| $123,594–$184,200 Antas III | Rahway, NJ | May 27, 2026 | Okt 1, 2026 | Sertipikado |
| $117,000–$184,200 Antas III | West Point, PA | May 22, 2026 | Okt 1, 2026 | Sertipikado |
| $123,594–$184,200 Antas III | Rahway, NJ | May 14, 2026 | Okt 1, 2026 | Sertipikado |
| $117,000–$184,200 Antas III | Rahway, NJ | May 14, 2026 | Okt 1, 2026 | Sertipikado |
| $114,700–$180,500 Antas I | Rahway, NJ | May 13, 2026 | Okt 1, 2026 | Sertipikado |
| $124,363–$184,200 Antas III | West Point, PA | May 5, 2026 | Okt 1, 2026 | Sertipikado |
| $124,363–$184,200 Antas III | Rahway, NJ | May 5, 2026 | Okt 1, 2026 | Sertipikado |
| $123,594–$184,200 Antas III | Rahway, NJ | Abr 20, 2026 | Okt 1, 2026 | Sertipikado |
| $114,700–$180,500 Antas II | Rahway, NJ | Hun 5, 2025 | Hul 7, 2025 | Sertipikado |
| $114,700–$180,500 Antas II | Rahway, NJ | Hun 5, 2025 | Hun 18, 2025 | Sertipikado |
| $114,700–$180,500 Antas II | Rahway, NJ | May 16, 2025 | Hul 24, 2025 | Sertipikado |
| $114,700–$180,500 Antas II | Rahway, NJ | May 13, 2025 | Okt 1, 2025 | Sertipikado |
| $119,787–$180,500 Antas III | Rahway, NJ | May 9, 2025 | Okt 1, 2025 | Sertipikado |
| $114,700–$180,500 Antas II | Rahway, NJ | Abr 30, 2025 | Okt 1, 2025 | Sertipikado |
| $114,700–$180,500 Antas II | Rahway, NJ | Abr 29, 2025 | Okt 1, 2025 | Sertipikado |
| $114,700–$180,500 Antas II | Rahway, NJ | Abr 28, 2025 | Okt 1, 2025 | Sertipikado |
| $114,700–$180,500 Antas II | Rahway, NJ | Abr 28, 2025 | Okt 1, 2025 | Sertipikado |
| $114,700–$180,500 Antas III | West Point, PA | Abr 28, 2025 | Okt 1, 2025 | Sertipikado |
| $111,400–$175,300 Antas II | Rahway, NJ | May 29, 2024 | Okt 1, 2024 | Sertipikado |
| $111,400–$175,300 Antas II | West Point, PA | May 21, 2024 | Okt 1, 2024 | Sertipikado |
| $111,400–$175,300 Antas II | Rahway, NJ | May 2, 2024 | Okt 1, 2024 | Sertipikado |
| $111,717–$169,400 Antas III | Kenilworth, NJ | May 17, 2023 | Okt 1, 2023 | Sertipikado |
| $111,717–$169,400 Antas III | Kenilworth, NJ | May 1, 2023 | Okt 1, 2023 | Sertipikado |
Iba pang trabaho sa Merck Sharp & Dohme LLC
- Senior Scientist, Statistical Programming$111,400
- Associate Principal Scientist, Statistical Programming$137,218
- Senior Scientist, Biostatistics$114,700
- Associate Principal Scientist, Biostatistics$139,600
- Senior Scientist, Analytical R&D$111,400
- Associate Scientist, Post Doc Fellow$75,982
- Senior Specialist, Data Science$122,800
- Senior Scientist, Chemistry$114,700
- Associate Principal Scientist, Analytical R&D$135,500
- Associate Director, Data Science$153,800
- Associate Principal Scientist, Outcomes Research$135,500
- Sr. Scientist, Chemistry$114,000
- Sr. Scientist, Biostatistics$113,050
- Senior Specialist - Software Engineering$131,997
- Scientist, Statistical Programming$91,600
- Sr. Specialist, Data Science$122,800
- Senior Specialist, Technical Product Management$123,338
- Senior Specialist - Data Engineering$133,900
- Associate Director, Technical Product Management$142,667
- Associate Principal Scientist, Preclinical Development$140,354
- Specialist, Data Science$108,306
- Associate Scientist, Post Doctoral Fellow$68,400
- Associate Director, Engineering, Development & Integration$139,600
- Senior Scientist, Engineering$123,594
Ang mga sahod ay ang mababang dulo ng alok na sweldo sa bawat aplikasyon, na isinalin sa taunang halaga; ginagamit lamang ng istatistika ang mga sertipikadong full-time na aplikasyon. Ang LCA ay hindi pag-apruba ng visa at maaaring saklawin ng isang LCA ang ilang posisyon. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (pinakabagong desisyon: Hun 30, 2026).